Certain statements in this report may constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Accordingly, stockholders should not assume that we agree with any statement or report issued by any analyst irrespective of the content of the statement or report.
Liquidity, Financial Position and Capital Resources – a discussion of our primary sources and uses of cash for the three month periods ended September 1, 2018 and September 2, 2017, and a discussion of changes in our financial position.
Richardson Electronics, Ltd. is a leading global provider of engineered solutions, power grid and microwave tubes and related consumables; power conversion and RF and microwave components; high value flat panel detector solutions, replacement parts, tubes and service training for diagnostic imaging equipment; and customized display solutions.
The Company’s strategy is to provide specialized technical expertise and “engineered solutions” based on our core engineering and manufacturing capabilities.
The Company provides solutions and adds value through design-in support, systems integration, prototype design and manufacturing, testing, logistics and aftermarket technical service and repair through its global infrastructure.
These products are used to control, switch or amplify electrical power signals, or are used as display devices in a variety of industrial, commercial, medical and communication applications.
Power and Microwave Technologies Group (“PMT”) combines our core engineered solutions, power grid and microwave tube business with new RF and power technologies.
As a manufacturer and authorized distributor, PMT’s strategy is to provide specialized technical expertise and engineered solutions based on our core engineering and manufacturing capabilities.
We provide solutions and add value through design-in support, systems integration, prototype design and manufacturing, testing, logistics and aftermarket technical service and repair—all through our existing global infrastructure.
PMT’s focus is on products for power, RF and microwave applications for customers in alternative energy, aviation, broadcast, communications, industrial, marine, medical, military, scientific and semiconductor markets.
PMT focuses on various applications including broadcast transmission, CO2 laser cutting, diagnostic imaging, dielectric and induction heating, high energy transfer, high voltage switching, plasma, power conversion, radar and radiation oncology.
PMT also offers its customers technical services for both microwave and industrial equipment.
Canvys provides customized display solutions serving the corporate enterprise, financial, healthcare, industrial and medical original equipment manufacturers markets.
Our engineers design, manufacture, source and support a full spectrum of solutions to match the needs of our customers.
We offer long term availability and proven custom display solutions that include touch screens, protective panels, custom enclosures, all-in-ones, specialized cabinet finishes and application specific software packages and certification services.
Our volume commitments are lower than the large display manufacturers, making us the ideal choice for companies with very specific design requirements.
Healthcare manufactures, refurbishes and distributes high value replacement parts for the healthcare market including hospitals, medical centers, asset management companies, independent service organizations and multi-vendor service providers.
Products include Diagnostic Imaging replacement parts for CT and MRI systems; replacement CT and MRI tubes; CT service training; MRI coils, cold heads and RF amplifiers; hydrogen thyratrons, klystrons, magnetrons; flat panel detector upgrades; and additional replacement solutions currently under development for the diagnostic imaging service market.
Through a combination of newly developed products and partnerships, service offerings and training programs, we believe we can help our customers improve efficiency and deliver better clinical outcomes while lowering the cost of healthcare delivery.
Net sales for the first quarter of fiscal 2019 were $44.2 million, an increase of 19.4%, compared to net sales of $37.0 million during the first quarter of fiscal 2018.
Gross margin decreased to 31.6% during the first quarter of fiscal 2019, compared to 32.8% during the first quarter of fiscal 2018.
Selling, general and administrative expenses were $13.1 million, or 29.7% of net sales, for the first quarter of fiscal 2019, compared to $12.3 million, or 33.3% of net sales, for the first quarter of fiscal 2018.
Operating income during the first quarter of fiscal 2019 was $0.9 million, compared to an operating income of less than $0.1 million in the first quarter of fiscal 2018.
During the first quarter of fiscal 2019, consolidated net sales increased 19.4% compared to the first quarter of fiscal 2018.
Sales for PMT increased 19.4%, sales for Canvys increased 24.4% and sales for Healthcare increased 5.2%.
The increase in PMT was due to market share gains in the RF and Microwave tube business as well as major growth in our new technology partners in power conversion and RF and Microwave components.
The increase for Canvys was due to increased customer demand in both our North American and European markets.
Consolidated gross margin as a percentage of net sales decreased to 31.6% during the first quarter of fiscal 2019, from 32.8% during the first quarter of fiscal 2018, primarily due to unfavorable product mix for PMT, unfavorable product mix and manufacturing variances for Richardson Healthcare, partially offset by favorable product mix and lower costs on selected products for Canvys.
PMT net sales increased 19.4% to $34.8 million during the first quarter of fiscal 2019, from $29.1 million during the first quarter of fiscal 2018.
The increase was due to market share gains in RF and Microwave tube business as well as major growth in our new technology partners in power conversion and RF and Microwave components.
Gross margin as a percentage of net sales decreased to 31.7% during the first quarter of fiscal 2019 as compared to 32.9% during the first quarter of fiscal 2018, due to unfavorable product mix.
Canvys net sales increased 24.4% to $7.2 million during the first quarter of fiscal 2019, from $5.8 million during the first quarter of fiscal 2018 due to increased customer demand in both our North American and European markets.
Gross margin as a percentage of net sales increased to 32.2% during the first quarter of fiscal 2019 as compared to 26.8% during the first quarter of fiscal 2018, due to favorable product mix and lower costs on selected products sold.
Healthcare net sales increased 5.2% to $2.2 million during the first quarter of fiscal 2019, from $2.1 million during the first quarter of fiscal 2018 due to increased Equipment and CT tube sales, partially offset by lower part sales.
Selling, general and administrative expenses increased to $13.1 million during the first quarter of fiscal 2019 from $12.3 million in the first quarter of fiscal 2018.
The increase was due to higher compensation and other expenses mostly related to the increase in net sales.
Operating expenses as a percent of net sales decreased to 29.7% in the first quarter of fiscal 2019 from 33.3% in the first quarter of fiscal 2018.
We recorded an income tax provision of $0.3 million and $0.1 million for the first three months of fiscal 2019 and the first three months of fiscal 2018, respectively.
The effective income tax rate during the first three months of fiscal 2019 was a tax provision of 38.6%, as compared to a tax provision of (133.3%) during the first three months of fiscal 2018.
The difference in rate during the first three months of fiscal 2019, as compared to the first three months of fiscal 2018, reflects the change from overall loss to overall income realized through the first quarter in each respective period, changes in our geographical distribution of income (loss), the recording of provision to return true-ups of various foreign jurisdictions and our positions with respect to ASC 740-30, Income Taxes - Other Considerations or Special Areas.
We are currently under examination in Thailand (fiscal 2008 through 2011).
We believe that the existing sources of liquidity, including current cash, will provide sufficient resources to meet known capital requirements and working capital needs through the next twelve months.
The cash used in operating activities primarily resulted from adjustments for non-cash items and changes in our operating assets and liabilities.
Operating activities used $3.6 million of cash during the first three months of fiscal 2019.
We had net income of $0.4 million during the first three months of fiscal 2019, which included non-cash stock-based compensation expense of $0.2 million associated with the issuance of stock option and restricted stock awards, $0.2 million for inventory reserve provisions and depreciation and amortization expense of $0.8 million associated with our property and equipment as well as amortization of our intangible assets.
Changes in our operating assets and liabilities resulted in a use of cash of $5.3 million during the first three months of fiscal 2019, net of foreign currency exchange gains and losses, included a decrease of $5.4 million in accounts payable and an increase in accounts receivable of $0.2 million, partially offset by an increase in accrued liabilities of $0.2 million.
The cash flow used in investing activities consisted primarily of purchases of investments and capital expenditures.
Cash used in investing activities of $3.4 million during the first three months of fiscal 2019 included $2.3 million from purchases of investments and $1.1 million in capital expenditures.
Capital expenditures relates primarily to our Healthcare growth initiatives, a new air conditioner unit for the building and capital used for our IT system.
Our purchases of investments consisted of a CD.
All future payments of dividends are at the discretion of the Board of Directors.
Dividend payments will depend on earnings, capital requirements, operating conditions and such other factors that the Board may deem relevant.
On October 10, 2018, we issued a press release reporting results for our first quarter ended September 1, 2018, and the declaration of a cash dividend.
We held our annual meeting of stockholders on October 9, 2018.
At the annual meeting, our stockholders (i) elected each of the nominees listed below to the Company's Board of Directors to serve for a term expiring at the 2019 Annual Meeting; (ii) ratified the selection of BDO USA, LLP as our independent registered public accounting firm for fiscal year 2019; (iii) approved, on an advisory basis, the compensation of the Company's named executive officers, and (iv) approved an amendment to the 2011 Long-Term Incentive Plan to increase the number of shares available under the plan.
The final results for the votes regarding each proposal are set forth below.
